Trial Profile
Monitoring Influenza Severity on Tamiflu (MIST)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Oct 2018
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Acronyms MIST
- 07 Dec 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 28 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Feb 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.